At a 33.8% CAGR |Global Therapeutic Vaccines Market Projected to
Worth USD 4.8 Billion by the end of 2021
The global therapeutic vaccines market is segmented into vaccine type such as
infectious disease vaccines, addiction vaccines, neurological disease vaccines and
autoimmune disease vaccines. Among these segments, infectious disease vaccines
segment is expected to witness satisfactory growth over the forecast period. The
growth of the infectious disease vaccines segment can be attributed to increasing
prevalence of infectious diseases such as HIV and other infectious diseases.
Moreover, it is used to provide immunity in human body to fight various infectious
Global therapeutic vaccines market is expected to register a 33.8% CAGR over the
forecast period. Moreover, the global therapeutic vaccines market is expected to
reach at revenue of around USD 4.8 Billion by the end of 2021. The market is
expected to expand on the back of increasing prevalence of infectious diseases such
as HIV, Cancer, hepatitis C, neurological diseases and others across the globe.
Moreover, increasing geriatric population is also a key factor which is fuelling the
demand for therapeutic vaccines.
The Asia Pacific region is likely to be fastest growing segment during the forecast
period. Improving healthcare infrastructure, rising geriatric population and
increased spending on R&D activities in healthcare sector are few of the key factors
which are envisioned to drive the growth of therapeutic vaccine market in Asia
Download Sample of This Strategic Report @
Increase in Incidence of Cancer
Cancer is one of the leading causes of deaths and was responsible for more than 8
million deaths in 2015, (according to WHO). During treatment of cancer,
therapeutic vaccines are one of the most important drugs/vaccines which are
provided to the patients to stimulate the immune system to target an infection.
Further, growing use of therapeutic